Adult with a Red Plaque at the Site of a Childhood Vaccination Scar
Am Fam Physician. 2009 Jun 1;79(11):995-996.
An 89-year-old patient presented with an asymptomatic lesion on her left proximal arm at the site of a childhood vaccination scar. The lesion had persisted for one and a half years. Physical examination revealed a 3.7-cm × 2.9-cm erythematous, ill-defined plaque with thin, overlying scale (see accompanying figure). There was no axillary lymphadenopathy. A full skin examination, including the oral mucosa, was otherwise unremarkable. Results of a potassium hydroxide preparation of a skin scraping were negative.
Based on the patient's history and physical examination, which one of the following is the most appropriate next step?
A. Intralesional steroid.
B. Skin biopsy.
C. Topical antifungal.
D. Topical emollient (e.g., petroleum jelly).
E. Topical steroid.
The answer is B: skin biopsy. There are a number of diseases that can lead to red plaques. However, a solitary, changing skin lesion occurring in a vaccination scar is highly suggestive of cutaneous malignancy and warrants a skin biopsy. In this patient, the histologic features are consistent with lentigo maligna melanoma, amelanotic type. Skin lesions not related to vaccines typically lead to more than one lesion in a characteristic distribution.
Although vaccination plays a significant role in disease prevention and maintenance of public health, rare adverse events (e.g., vaccine-associated malignancy) may occur. Basal cell carcinoma is the most commonly reported neoplastic proliferation in vaccination scars and has occurred with smallpox and bacille Calmette-Guérin (BCG) vaccines.1-2 Squamous cell carcinoma,1-2 melanoma,1 dermatofibrosarcoma protuberans,3 and malignant fibrous histiocytoma4 have also been reported in vaccination scars. It is impossible to draw conclusions about predominance in males versus females, age of presentation, and incidence of vaccination because few cases have been reported.5
Although the pathogenesis remains unknown, vaccine-associated malignancies (e.g., Marjolin ulcer, squamous cell carcinoma) may be secondary to chronic inflammation. Although the smallpox and BCG vaccines are live, a component of the vaccines may cause prolonged inflammation. Additionally, the route of administration may contribute to carcinogenesis. Unlike other vaccines, smallpox vaccines are administered by scarification and BCG vaccines by intradermal injection.6 These routes may introduce keratin intradermally, causing a subsequent foreign body granuloma.
Vaccine-associated feline sarcoma may provide insight into the pathogenesis of vaccine-associated malignancies in humans.7 Studies suggest that persistent inflammation from vaccine adjuvants, such as aluminum, is the major factor for carcinogenesis in vaccine-associated feline sarcoma. Epidemiologic evidence supports both a causal and a dose-response relationship between adjuvanted vaccines and development of sarcoma at the vaccination site.
The diagnosis of a skin lesion in a vaccination scar should be confirmed with skin biopsy. Treatment goals depend on the type of cutaneous malignancy diagnosed. The posttreatment course should include periodic skin examinations for tumor recurrence and new primary skin cancers.
A topical emollient (e.g., petroleum jelly) is appropriate for moisturization of xerosis (dry skin). The use of steroids should be restricted to inflammatory skin conditions. Topical antifungal medications are used for dermatophyte infections.
Selected Differential Diagnosis of Red Plaques
Selected Differential Diagnosis of Red Plaques
Red, poorly defined papules and plaques with adherent scale; usually involves multiple lesions in sun-exposed areas
Violaceous, polygonal papules and plaques with overlying fine white lines (Wickham striae); usually involves the wrists, lower back, and ankles
Pruritic, scaly, erythematous patches and plaques affecting numerous body surfaces; often occurs with xerosis (dry skin)
Well-circumscribed, salmon-colored plaques that bleed when the overlying silver-to-white scale is peeled from the plaque (Auspitz sign); usually involves areas of friction (e.g., elbows, knees, umbilicus, gluteal cleft)
Mildly pruritic, scaly, oval-to-round, red patches; common in body folds; diagnosis is confirmed with microscopy or culture of skin scrapings
1. Marmelzat WL. Malignant tumors in smallpox vaccination scars: a report of 24 cases. Arch Dermatol. 1968;97(4):400–406.
2. Reed WB, Wilson-Jones E. Malignant tumors as a late complication of vaccination. Arch Dermatol. 1968;98(2):132–135.
3. Green JJ, Heymann WR. Dermatofibrosarcoma protuberans occurring in a smallpox vaccination scar. J Am Acad Dermatol. 2003;48(5 suppl):S54–55.
4. Slater DN, Parsons MA, Fussey IV. Malignant fibrous histiocytoma arising in a smallpox vaccination scar. Br J Dermatol. 1981;105(2):215–217.
5. Braithwaite IJ, Miller G, Burd DA. Basal cell carcinoma in a BCG scar in a young woman. Case report. Scand J Plast Reconstr Surg Hand Surg. 1992;26(2):233–234.
6. Pirofski LA, Casadevall A. Use of licensed vaccines for active immunization of the immunocompromised host. Clin Microbiol Rev. 1998;11(1):1–26.
7. Vaccine-Associated Feline Sarcoma Task Force. The current understanding and management of vaccine-associated sarcomas in cats. J Am Vet Med Assoc. 2005;226(11):1821–1842.
The editors of AFP welcome submissions for Photo Quiz. Guidelines for preparing and submitting a Photo Quiz manuscript can be found in the Authors' Guide at http://www.aafp.org/afp/photoquizinfo. To be considered for publication, submissions must meet these guidelines. E-mail submissions to email@example.com.
Copyright © 2009 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact firstname.lastname@example.org for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions